Jove
Visualize
Contact Us

Related Experiment Videos

Emerging opportunists.

M G Rinaldi1

  • 1Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center, San Antonio.

Infectious Disease Clinics of North America
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Opportunistic fungal infections are rising due to increased immunosuppressed patients. Clinicians and laboratorians must suspect mycoses caused by yeasts and molds, emphasizing the need for better diagnosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Antimicrobial agents and chemotherapy·2011
Same author

Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples.

Journal of clinical microbiology·2011
Same author

Spectrum of clinically relevant Acremonium species in the United States.

Journal of clinical microbiology·2010
Same author

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Journal of clinical microbiology·2010
Same author

Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Journal of clinical microbiology·2010
Same author

Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeasts.

Journal of clinical microbiology·2009
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Increasing prevalence of opportunistic fungal pathogens.
  • Growing population of immunosuppressed individuals at risk.
  • Need for heightened awareness of fungal infections in clinical settings.

Observation:

  • Opportunistic fungal pathogens, including yeasts and molds, are becoming more numerous and diverse.
  • The trend of increasing fungal infections is expected to continue.
  • Current diagnostic and therapeutic methods require improvement.

Findings:

  • Fungal agents responsible for mycoses span the entire fungal kingdom.
  • Clinicians and laboratorians play a crucial role in identifying these infections.
  • A proactive approach, or "thinking fungus," is essential.

Related Experiment Videos

Implications:

  • Urgent need for enhanced diagnostic techniques for fungal infections.
  • Development of improved antifungal therapies is critical.
  • Medical professionals must prioritize fungal awareness in patient care to combat rising mycoses.